Related Experiment Video
Updated: Apr 13, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Published on: June 2, 2015
Long-term, regular remote ischemic preconditioning improves endothelial function in patients with coronary heart
1Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Insights
Long-term remote ischemic preconditioning (RIPre) significantly improves arterial endothelial function in patients with coronary heart disease (CHD). This intervention, involving repeated blood flow occlusion and reperfusion, enhances flow-mediated dilation and increases endothelial progenitor cells.
Area of Science:
- Cardiovascular Research
- Vascular Biology
- Regenerative Medicine
Background:
- Coronary artery disease (CHD) is a leading cause of mortality.
- Endothelial dysfunction is a key factor in CHD pathogenesis.
- Remote ischemic preconditioning (RIPre) shows potential for cardioprotection.
Purpose of the Study:
- To evaluate the long-term effects of regular RIPre on human arterial endothelial function.
- To investigate the impact of RIPre on endothelial progenitor cells and underlying molecular mechanisms in patients with CHD.
Main Methods:
- Forty patients undergoing coronary artery bypass graft (CABG) surgery were randomized into RIPre and CHD groups (n=20 each).
- A control group (n=20) of mastectomy patients was included.
- RIPre involved cycles of 5-minute arterial occlusion followed by 5-minute reperfusion, repeated 4 times, 3 times daily for 20 days.
- Endothelial function (flow-mediated dilation - FMD), CD34(+) monocyte count, eNOS expression, and STAT-3/Akt phosphorylation were assessed in arterial samples.
Main Results:
- Long-term RIPre significantly improved FMD in the RIPre group compared to the CHD group (8.5±2.4% vs 4.9±4.2%, P<0.05).
- Troponin levels post-CABG surgery were significantly reduced in the RIPre group.
- RIPre activated STAT-3 signaling and increased CD34(+) endothelial progenitor cell counts.
Conclusions:
- Regular, long-term RIPre enhances endothelial function in patients with CHD.
- STAT-3 activation appears to be a key mechanism mediating RIPre's benefits.
- RIPre may promote vascular repair through an increase in endothelial progenitor cells.
Abstract:
Remote ischemic preconditioning (RIPre) can prevent myocardial injury. The purpose of this study was to assess the beneficial effects of long-term regular RIPre on human arteries. Forty patients scheduled for coronary artery bypass graft (CABG) surgery were assigned randomly to a RIPre group (n=20) or coronary heart disease (CHD) group (n=20). Twenty patients scheduled for mastectomy were enrolled as a control group. RIPre was achieved by occluding arterial blood flow 5 min with a mercury sphygmomanometer followed by a 5-min reperfusion period, and this was repeated 4 times. The RIPre procedure was repeated 3 times a day for 20 days. In all patients, arterial fragments discarded during surgery were collected to evaluate endothelial function by flow-mediated dilation (FMD), CD34(+) monocyte count, and endothelial nitric oxide synthase (eNOS expression). Phosphorylation levels of STAT-3 and Akt were also assayed to explore the underlying mechanisms. Compared with the CHD group, long-term regular RIPre significantly improved FMD after 20 days (8.5±2.4 vs 4.9±4.2%, P<0.05) and significantly reduced troponin after CABG surgery (0.72±0.31 and 1.64±0.19, P<0.05). RIPre activated STAT-3 and increased CD34(+) endothelial progenitor cell counts found in arteries. Long-term, regular RIPre improved endothelial function in patients with CHD, possibly due to STAT-3 activation, and this may have led to an increase in endothelial progenitor cells.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology

